What is the diagnosis and appropriate management for pearly‑white, dome‑shaped papules on the skin of a healthy child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pearly White Nodules in Children

The diagnosis is molluscum contagiosum, a self-limited viral infection that presents as flesh-colored or pearly white, dome-shaped papules with central umbilication, most commonly affecting preschool and elementary school-aged children. 1, 2

Clinical Diagnosis

The characteristic features that confirm molluscum contagiosum include:

  • Pearly white or flesh-colored, smooth, dome-shaped papules measuring 2-6 mm in diameter with central umbilication from which a cheesy plug of material can be expressed 1, 3, 2
  • Lesions typically appear on the trunk, extremities, and face in children (versus genital region in sexually active adults) 4, 3
  • Dermoscopy reveals yellowish-white polylobulated structures with peripheral telangiectasia, which can confirm the diagnosis when clinical appearance is unclear 5
  • The infection is caused by molluscipox virus of the Poxviridae family and spreads through direct skin contact, autoinoculation, and fomites 1, 3

A common pitfall is confusing molluscum with other conditions. The shiny, dome-shaped umbilicated lesions distinguish molluscum from verruca vulgaris (which has a white pebbly or papillary surface) 6, and from the red, telangiectatic macules of telangiectasia macularis eruptiva persistans 6.

Management Algorithm

The primary decision is whether to observe or actively treat, based on lesion extent, complications, and family preference:

Observation (Watchful Waiting)

  • Appropriate for limited, asymptomatic lesions in immunocompetent children 3
  • Natural resolution typically occurs within 6-9 months, though lesions may persist for months to years 1, 3
  • Spontaneous regression is common and avoids treatment-related discomfort 6

Active Treatment Indications

Active treatment should be pursued when: 1

  • Extensive disease is present
  • Complications develop (perilesional eczema, bacterial superinfection, BOTE sign) 5
  • Aesthetic concerns exist
  • Risk of transmission to others or autoinoculation is high 4, 3

Treatment Options (in order of preference)

Physical destruction methods:

  • Cryotherapy with liquid nitrogen is the method of choice for most patients 3
  • Curettage provides immediate removal but requires local anesthesia 3
  • Pulsed dye laser therapy for resistant cases 3

Chemical destruction:

  • Cantharidin application is highly effective and well-tolerated 3
  • Potassium hydroxide, trichloroacetic acid, or salicylic acid preparations 1, 3

Immunomodulatory therapy:

  • Topical imiquimod 5% cream once daily under occlusion achieved complete remission in 73.91% of children within 3-8 weeks in clinical practice 4
  • Mild to moderate local irritation is the only adverse effect; no systemic side effects occur 4
  • Despite unpublished FDA trials suggesting lack of efficacy, multiple peer-reviewed studies demonstrate safety and effectiveness in real-world practice 4

Important Caveats

Immunocompromised patients may develop atypical manifestations including giant, disseminated, necrotic, polypoidal, or nodular lesions that complicate diagnosis and management 5. These patients require more aggressive treatment approaches.

Associated inflammatory reactions can mimic other dermatological conditions, including perilesional eczema, Gianotti-Crosti syndrome-like reaction, ID reaction, erythema annulare centrifugum, and folliculitis 5. Recognition of these patterns prevents unnecessary treatments for misdiagnosed conditions.

The choice of treatment method depends on: 3

  • Physician comfort with various options
  • Patient age and cooperation
  • Number, severity, and location of lesions
  • Family preference regarding intervention versus observation

No FDA-approved treatments exist for molluscum contagiosum, but the evidence strongly supports both observation and active treatment as reasonable approaches depending on clinical circumstances 1, 4, 3.

References

Research

Common Skin Rashes in Children.

American family physician, 2015

Research

Molluscum Contagiosum: An Update.

Recent patents on inflammation & allergy drug discovery, 2017

Research

[Skin reactions related to molluscum contagiosum infection].

Andes pediatrica : revista Chilena de pediatria, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the cause of Molluscum contagiosum?
What is the most likely diagnosis for a 2-year-old boy with a history of atopic dermatitis, presenting with multiple flesh-colored, dome-shaped, pearly lesions with central depressions on his arms, which are different from his usual atopic dermatitis in appearance and location, and are not itchy?
What is the recommended treatment for molluscum contagiosum in a 4-year-old (YOM - Years Old Male)?
What is the diagnosis and treatment for a 7-year-old female with a painful, flesh-colored bump on her upper arm, which has worsened after attempted popping and has a possible family history of molluscum contagiosum?
What is the diagnosis and recommended treatment for a patient presenting with a fever and a cluster of 2mm, flesh-colored, dome-shaped bumps with smooth central umbilication on their trunk and armpits, lasting several weeks without pain or itching?
In an otherwise healthy adult with a lip abscess caused by Staphylococcus aureus and no penicillin allergy or MRSA risk factors, what oral antibiotic regimen is recommended?
What is the appropriate management of hypokalemia in a patient on regular dialysis?
What is the recommended management for infectious mononucleosis in an adolescent, including supportive care, activity restrictions, medication use, and indications for corticosteroids?
What patient education should I give a patient with foot drop about treatment options such as ankle‑foot orthosis (AFO) or functional electrical stimulation (FES), home exercises, skin care, and follow‑up?
How does apixaban affect prothrombin time (PT) and activated partial thromboplastin time (aPTT)?
Can Lyrica (pregabalin) be used to treat sensory processing difficulties in children with autism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.